What it means
Photobiomodulation (PBM) is the application of low-level red (600–700 nm) or near-infrared (780–1,000 nm) light to tissue. The main target is cytochrome c oxidase in the mitochondria, which absorbs these wavelengths; the proposed result is more ATP, a brief burst of reactive oxygen species that triggers a hormetic response, and release of nitric oxide that improves local blood flow.
Dose is measured in joules per square centimetre at the skin, and the response is biphasic: too little does nothing, too much inhibits. Most consumer panels are under-powered at the distances people use them.
Why it matters for longevity
If a non-invasive light could improve mitochondrial function in skin, muscle or brain, it would be a cheap addition to any plan. The evidence supports specific, local uses; the "whole-body mitochondrial rejuvenation" claim is not one of them.
What the evidence says
Strongest: oral mucositis from chemotherapy (guideline-recommended), tendinopathy and musculoskeletal pain (meta-analyses show moderate effects at the right dose), skin photoageing (Wunsch 2014, 136 adults, improved collagen density and roughness over 30 sessions), and androgenetic hair loss (several randomised trials).
Moderate to early: muscle recovery and performance when applied before exercise (small trials, consistent direction), wound healing, and transcranial PBM for cognition (pilot trials only). No evidence for fat loss, testosterone or longevity outcomes. The 2024 review by Hamblin and colleagues notes that most negative trials used doses outside the effective window.
How to measure or use it
- No biomarker; judge it on the local endpoint — skin texture at 12 weeks, pain scores, recovery between sessions.
- Dose in the trials: roughly 4–10 J/cm² at the skin, which needs a device of 50–100 mW/cm² at a few centimetres for one to three minutes per area, three to five times a week.
- Eye protection with near-infrared; no benefit from longer sessions — more is not more.
Related
- Red light therapy — the full therapy page, graded
- Skin and collagen ageing — the skin evidence in context
- GHK-Cu (research page) — a research peptide studied for skin
Frequently asked questions
Does red light therapy work?
For skin ageing, some pain conditions, hair loss and oral mucositis, randomised trials support it at the right dose. For fat loss, testosterone or longevity, no.
What wavelength is best?
Red at 630–660 nm for skin; near-infrared at 810–850 nm for deeper tissue. Many devices combine both.
How close and how long?
Close enough to reach 50–100 mW/cm² — usually 10–20 cm — for one to three minutes per area. Check the manufacturer's measured irradiance, not the LED wattage.
Want this applied to your own numbers?
Fifteen minutes of intake, your labs, a human-reviewed protocol within about 24 hours, three documents, a free coach call and check-ins through the cycle. €399, follow-up included.
Build my protocol Book a 15-minute call